2024-03-16 08:00 | UU:GSK | | News Release200 | Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer |
2024-03-07 12:00 | UU:GSK | | News Release200 | GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise |
2024-02-08 07:00 | UU:GSK | | News Release200 | Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer ¢ € ™s Disease |
2024-02-07 16:01 | UU:GSK | | News Release200 | 23andMe Reports Third Quarter Fiscal 2024 Financial Results |
2024-02-07 07:00 | UU:GSK | | News Release200 | FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) |
2024-02-06 07:00 | UU:GSK | | News Release200 | GSK ¢ € ™s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk |
2024-01-24 08:00 | UU:GSK | | News Release200 | Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen ¢ € ™s Cell-Free DNA Production Technology |
2024-01-09 05:52 | UU:GSK | | News Release200 | GSK Enters Agreement to Acquire Aiolos Bio |
2023-12-12 08:00 | UU:GSK | | News Release200 | GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity |
2023-11-13 08:00 | UU:GSK | | News Release200 | GSK and Queer Eye ¢ € ™s Thom Filicia Partner on Blood Cancer Awareness Initiative |
2023-10-30 08:00 | UU:GSK | | News Release200 | 23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK |
2023-10-27 07:00 | UU:GSK | | News Release200 | Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) |
2023-10-25 07:00 | UU:GSK | | News Release200 | New Data for AREXVY, GSK ¢ € ™s RSV Vaccine, Show Potential to Help Protect Adults Aged 50 to 59 at Increased Risk for RSV Disease |
2023-10-12 09:00 | UU:GSK | | News Release200 | Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032 |
2023-09-15 19:26 | UU:GSK | | News Release200 | Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia |
2023-09-05 08:00 | UU:GSK | | News Release200 | GSK and Earvin ¢ € œMagic ¢ € Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations |
2023-08-17 08:00 | UU:GSK | | News Release200 | GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies |
2023-07-31 14:42 | UU:GSK | | News Release200 | Jemperli (dostarlimab-gxly) plus chemotherapy approved in the US as the first new frontline treatment option in decades for dMMR/MSI-H primary advanced or recurrent endometrial cancer |
2023-07-13 08:23 | UU:GSK | | News Release200 | GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US |
2023-06-28 10:57 | UU:GSK | | News Release200 | Stock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health |
2023-06-21 20:26 | UU:GSK | | News Release200 | US Centers for Disease Control and Prevention ¢ € ™s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making |
2023-06-21 08:00 | UU:GSK | | News Release200 | GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons |
2023-06-20 08:00 | UU:GSK | | News Release200 | GSK and Lifetime ‚ ® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to ¢ € œAsk2BSure ¢ € about Meningitis B |
2023-06-01 08:00 | UU:GSK | | News Release200 | GSK Announces the COiMMUNITY Initiative to Help Achieve Higher Adult Vaccination Rates in the US |
2023-05-16 17:01 | UU:GSK | | News Release200 | BELLUS Health Inc. Calls Special Shareholders ¢ € ™ Meeting in Connection with GSK Acquisition |
2023-05-11 12:15 | UU:GSK | | News Release200 | SpringWorks Therapeutics Announces Clinical Data Presentations of Nirogacestat in Combination with BCMA-Directed Therapies at the European Hematology Association 2023 Congress |
2023-05-11 07:00 | UU:GSK | | News Release200 | SCYNEXIS Announces First Quarter 2023 Financial Results and Provides Corporate Update |